Literature DB >> 19110313

Vanadium compounds as therapeutic agents: some chemical and biochemical studies.

H Faneca1, V A Figueiredo, Isabel Tomaz, Gisela Gonçalves, Fernando Avecilla, M C Pedroso de Lima, Carlos F G C Geraldes, João Costa Pessoa, M Margarida C A Castro.   

Abstract

The behaviour of three vanadium(V) systems, namely the pyridinone (V(V)-dmpp), the salicylaldehyde (V(V)-salDPA) and the pyrimidinone (V(V)-MHCPE) complexes, is studied in aqueous solutions, under aerobic and physiological conditions using (51)V NMR, EPR and UV-Visible (UV-Vis) spectroscopies. The speciations for the V(V)-dmpp and V(V)-salDPA have been previously reported. In this work, the system V(V)-MHCPE is studied by pH-potentiometry and (51)V NMR. The results indicate that, at pH ca. 7, the main species present are (V(V)O(2))L(2) and (V(V)O(2))LH(-1) (L=MHCPE(-)) and hydrolysis products, similar to those observed in aqueous solutions of V(V)-dmpp. The latter species is protonated as the pH decreases, originating (V(V)O(2))L and (V(V)O(2))LH. All the V(V)-species studied are stable in aqueous media with different compositions and at physiological pH, including the cell culture medium. The compounds were screened for their potential cytotoxic activity in two different cell lines. The toxic effects were found to be incubation time and concentration dependent and specific for each compound and type of cells. The HeLa tumor cells seem to be more sensitive to drug effects than the 3T3-L1 fibroblasts. According to the IC(50) values and the results on reversibility to drug effects, the V(V)-species resulting from the V(V)-MHCPE system show higher toxicity in the tumor cells than in non-tumor cells, which may indicate potential antitumor activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19110313     DOI: 10.1016/j.jinorgbio.2008.11.004

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  5 in total

1.  Vanadium compounds discriminate hepatoma and normal hepatic cells by differential regulation of reactive oxygen species.

Authors:  Qin Wang; Tong-Tong Liu; Ying Fu; Kui Wang; Xiao-Gai Yang
Journal:  J Biol Inorg Chem       Date:  2010-05-05       Impact factor: 3.358

2.  Antidiabetic vanadium compound and membrane interfaces: interface-facilitated metal complex hydrolysis.

Authors:  Debbie C Crans; Samantha Schoeberl; Ernestas Gaidamauskas; Bharat Baruah; Deborah A Roess
Journal:  J Biol Inorg Chem       Date:  2011-06-11       Impact factor: 3.358

3.  Copper(II) and oxidovanadium(IV) complexes of chromone Schiff bases as potential anticancer agents.

Authors:  Patrique Nunes; Yasemin Yildizhan; Zelal Adiguzel; Fernanda Marques; João Costa Pessoa; Ceyda Acilan; Isabel Correia
Journal:  J Biol Inorg Chem       Date:  2021-11-24       Impact factor: 3.358

Review 4.  Vanadium. Its role for humans.

Authors:  Dieter Rehder
Journal:  Met Ions Life Sci       Date:  2013

Review 5.  Vanadium compounds in medicine.

Authors:  Joao Costa Pessoa; Susana Etcheverry; Dinorah Gambino
Journal:  Coord Chem Rev       Date:  2014-12-09       Impact factor: 22.315

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.